title: [Mondor's thrombophlebitis and antiphospholipid antibodies].
authors.forename: Nadine
authors.initials: N
authors.lastname: Magy
authors.forename: Helder
authors.initials: H
authors.lastname: Gil
authors.forename: Evelyne
authors.initials: E
authors.lastname: Racadot
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Dupond
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D017152:Antibodies, Antiphospholipid; D016736:Antiphospholipid Syndrome / Q000175:diagnosis*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D019693:Hepatitis, Autoimmune / Q000150:complications*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013577:Syndrome; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000188:drug therapy; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D017152:Antibodies, Antiphospholipid; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin